Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...
GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer and UCB. The departures coincided with ...
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space ...
MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...
The company ended the quarter with $192 million in cash and equivalents, enough to fund operations past 2027. 2seventy Bio ...
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, ...
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
Bio-based materials may pose a greater health risk to some of the planet's most important species than the conventional ...
CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback